This is a Phase 1/2, open-label, multi-center, dose escalation (Part 1), dose expansion (Part 2), and single repeat dose (Part 3) study to evaluate the safety,…

Alpha-1 Antitrypsin Deficiency (AATD)

~Estimated

~$10 – $8,750

Tessera Therapeutics, Inc.NCT07227207

The Role of Conformational Diseases on Macrophage Function

The purpose of this study is to look at how Alpha-1-antitrypsin (AAT) deficiency and Cystic Fibrosis (CF) affect white blood cells in the lungs, called macroph…

Alpha-1 Antitrypsin DeficiencyAAT DeficiencyAATD+1 more

~Estimated

~$10 – $750

University of FloridaNCT01851642

The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

The Alpha-1 Coded Testing (ACT) Study was established to study genetic testing and outcomes of individuals at risk for alpha-1 antitrypsin deficiency.

Alpha-1 Antitrypsin Deficiency

~Estimated

~$10 – $750

University of FloridaNCT00500123